Substance Use Disorders News

Enveric Biosciences announced it has signed a nonbinding term sheet to out-license a class of novel psilocin prodrugs to MindBio Therapeutics, an agreement that could yield more than $66 million in sales.

NEW YORK — Administering marijuana to patients who may benefit from its therapeutic properties is a “complex sociopolitical and medical” issue, Brody Montoya, DO, says in this Healio video from the American Psychiatric Association annual meeting.

NEW YORK — The American Psychiatric Association successfully disseminated education among the public and physicians highlighting addiction psychiatry as part of its presidential initiative, the group’s outgoing president said at its annual meeting.

NEW YORK — FDA regulations and Instagram content policies designed to minimize youth exposure to content promoting electronic nicotine delivery systems are not well enforced, according to recent research.

NEW YORK — A state with retail access to cannabis reported no decline in use during the COVID-19 pandemic compared with a state having no retail access, according to research presented at the American Psychiatric Association annual meeting.

The U.S. Drug Enforcement Administration is proposing to reclassify marijuana as a less dangerous drug, moving it from a Schedule I to Schedule III substance.

The FDA has approved an abbreviated new drug application for naloxone hydrochloride nasal spray, paving the way for the opioid overdose treatment to be available without a prescription.

Some antipsychotics other than olanzapine lowered the risk for hospitalization due to psychotic relapse among individuals with first-episode psychosis and co-occurring cannabis use disorder, according to a study in Schizophrenia Bulletin.

An alcohol brief intervention, along with mobile-based instant messaging, reduced alcohol use and intention to drink among college students, according to a study published in JAMA Internal Medicine.

The risk for mental health conditions and self-harm or suicide was higher among partners and adult offspring of stroke survivors vs. the general population and family of myocardial infarction survivors, according to a study in Denmark.